China Pharma Holdings Inc (CPHI) Stock Analysis

China Pharma Holdings Inc (CPHI) is a publicly traded company in the HEALTHCARE sector. It trades at $0.80, carries a market capitalization of $32.16M. This page summarizes the public market data, fundamentals, and frequently asked questions for CPHI, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE MKT

Key Metrics

• Price: $0.80
• Market Cap: $32.16M
• EPS: $-0.54
• 52-Week High: $2.05
• 52-Week Low: $0.50

Market Sentiment

China Pharma Holdings Inc currently has a Neutral sentiment score of 0.04.

About China Pharma Holdings Inc

China Pharma Holdings, Inc. (CPHI) is a prominent player in the Chinese pharmaceutical sector, specializing in the development, manufacturing, and marketing of both generic and branded medical products. The company primarily serves hospitals and private retail outlets within the People's Republic of China, emphasizing its commitment to high-quality healthcare solutions. With its headquarters in Haikou, China, CPHI is strategically poised to capitalize on the burgeoning pharmaceutical market, ...

GNG Research Analysis

GNG Research scores China Pharma Holdings Inc (CPHI) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CPHI.

Frequently Asked Questions

Does CPHI pay dividends?

China Pharma Holdings Inc (CPHI) does not currently pay a regular dividend.

What is CPHI's market cap?

China Pharma Holdings Inc (CPHI) has a market capitalization of $32.16M with a current stock price of $0.80.